Diabetes Research and Clinical Practice
Volume 86, Issue 3 , Pages 225-232 , December 2009

Improvements in risk factor control among persons with diabetes in the United States: Evidence and implications for remaining life expectancy

  • Thomas J. Hoerger

      Affiliations

    • RTI International, Research Triangle Park, NC, United States
    • Corresponding Author InformationCorresponding author at: RTI-UNC Center of Excellence in Health Promotion Economics, RTI International, 3040 Cornwallis Road, P.O. Box 12194, Research Triangle Park, NC 27709, United States. Tel.: +1 919 541 7146; fax: +1 919 541 6683.
    • ,
  • Ping Zhang

      Affiliations

    • Centers for Disease Control and Prevention, Atlanta, GA, United States
    • ,
  • Joel E. Segel

      Affiliations

    • RTI International, Research Triangle Park, NC, United States
    • ,
  • Edward W. Gregg

      Affiliations

    • Centers for Disease Control and Prevention, Atlanta, GA, United States
    • ,
  • K.M. Venkat Narayan

      Affiliations

    • Rollins School of Public Health, Emory University, Atlanta, GA, United States
    • ,
  • Katherine A. Hicks

      Affiliations

    • RTI International, Research Triangle Park, NC, United States

Received 27 March 2009 ,Accepted 17 September 2009.

References 

  1. Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet. 2005;365(9467):1333–1346
  2. American Diabetes Association . Standards of medical care in diabetes—2008. Diabetes Care. 2008;31(Suppl. 1):S12–S54
  3. National Diabetes Education Program, 4 Steps to Control your Diabetes for Life. NIH Publication 06-5492, October 2006.
  4. Imperatore G, Cadwell BL, Geiss L, Saaddine JB, Ford ES, Narayan KM, et al. Thirty-year trends in cardiovascular risk factor levels among US adults with diabetes: National Health and Nutrition Examination Surveys, 1971–2000. Am. J. Epidemiol. 2004;160(September (6)):531–539
  5. Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004;291(3):335–342
  6. Koro CE, Bowlin SJ, Bourgeois N, Fedder DO. Glycemic control from 1988 to 2000 among US adults with diagnosed type II diabetes. Diabetes Care. 2004;27(1):17–20
  7. Saaddine JB, Cadwell B, Gregg EW, Engelgau MM, Vinicor F, Imperatore G, et al. Improvements in diabetes processes of care and intermediate outcomes: United States, 1988–2002. Ann. Intern. Med. 2006;144(7):465–474
  8. Hoerger TJ, Segel JE, Gregg EW, Saaddine JB. Is glycemic control improving in U.S. adults?. Diabetes Care. 2008;31(1):81–86
  9. Ford ES, Li C, Little RR, Mokdad AH. Trends in A1c concentrations among US adults with diagnosed diabetes from 1999 to 2004. Diabetes Care. 2008;31(1):102–104
  10. National Center for Health Statistics, National Health and Nutrition Examination Summary, Data Sets and Related Documentation, U.S. Department of Health and Human Service, Centers for Disease Control and Prevention, National Center for Health Statistics, Hyattsville, MD, Available at: http://www.cdc.gov/nchs/about/major/nhanes/datalink.htm, Accessed April 16, 2008.
  11. StataCorp. . Stata Statistical Software, Release 9. College Station, TX: StataCorp LP; 2005;
  12. National Center for Health Statistics, HDL Cholesterol, U.S. Department of Health and Human Service, Centers for Disease Control and Prevention, National Center for Health Statistics, Hyattsville, MD, Available at: http://www.cdc.gov/nchs/data/nhanes/nhanes_05_06/hdl_d.pdf, Accessed May 13, 2008.
  13. The CDC Diabetes Cost-effectiveness Group (Corresponding Author: TJ Hoerger) . Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes. JAMA. 2002;287(19):2542–2551
  14. UK Prospective Diabetes Study Group (UKPDS 33) . Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet. 1998;352(9131):837–853
  15. Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int. 2003;63(1):225–232
  16. Stevens RJ, Kothari V, Adler AI, Stratton IM. The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56). Clin. Sci. (Lond.). 2001;101(6):671–679
  17. Kothari V, Stevens RJ, Adler AI, Stratton IM, Manley SE, Neil HA, et al. UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK prospective diabetes study risk engine. Stroke. 2002;33(7):1776–1781
  18. Centers for Disease Control and Prevention, Incidence of Diabetes in the Population Aged 18–79, March 2007a, Available at: http://www.cdc.gov/diabetes/statistics/incidence_national.htm, Accessed January 11, 2008.
  19. Leal J, Gray AM, Clarke PM. Development of life-expectancy tables for people with type 2 diabetes. Eur. Heart J. 2009;30:834–839
  20. Cholesterol Treatment Trialists’ (CTT) Collaborators . Efficacy of cholesterol-lowering therapy in 18686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet. 2008;371(9607):117–125
  21. National Institutes of Health, For safety, NHLBI Changes Intensive Blood Sugar Treatment Strategy in Clinical Trial of Diabetes and Cardiovascular Disease, February 08, 2008, Available at: http://public.nhlbi.nih.gov/newsroom/home/GetPressRelease.aspx?id=2551, Accessed March 3, 2008.
  22. The George Institute, Major International Diabetes Study Does not Confirm Increased Risk of Death Reported by US Trial, Media release, February 2008, Available at: http://www.advance-trial.com/static/upload/PDF/Media_release_Feb08.pdf, Accessed April 22, 2008.
  23. Dinneen SF, Maldonado D, Leibson CL, Klee GG, Melton LJ, Rizza RA. Effects of changing diagnostic criteria on the risk of developing diabetes. Diabetes Care. 1998;21:1408–1413
  24. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus . Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003;26:3160–3167
  25. Hoerger, T.J., Segel, J.E., Zhang, P., and Sorensen, S.W. (2009). Validation of the CDC-RTI Diabetes Cost-Effectiveness Model. RTI Press publication No. MR-0013-0909. Research Triangle Park, NC: RTI International. Retrieved September 29, 2009 from http://www.rti.org/rtipress.
  26. Centers for Disease Control and Prevention, Age-adjusted Rates of Current Smoking per 100 Adults with Diabetes, United States, 1994–2004, March 2007, Available at: http://www.cdc.gov/diabetes/statistics/comp/fig7_smoking.htm, Accessed March 25, 2008.
  27. Centers for Disease Control and Prevention, Annual Number (in Thousands) of New Cases of Diagnosed Diabetes Among Adults Aged 18–79 years, United States, 1980–2005, March 2007, Available at: http://www.cdc.gov/diabetes/statistics/incidence/fig1.htm, Accessed May 21, 2008.
  28. Centers for Disease Control and Prevention, Crude and Age-adjusted Prevalence of Diagnosed Diabetes per 100 Population, United States, 1980–2005, March 2007, Available at: http://www.cdc.gov/diabetes/statistics/prev/national/figage.htm, Accessed March 7, 2008.
  29. Narayan KM, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF. Lifetime risk for diabetes mellitus in the United States. JAMA. 2003;290(October (14)):1884–1890

PII: S0168-8227(09)00409-4

doi: 10.1016/j.diabres.2009.09.017

Diabetes Research and Clinical Practice
Volume 86, Issue 3 , Pages 225-232 , December 2009

Article Tools

* Image Usage & Resolution